30 related articles for article (PubMed ID: 21155813)
1. External magnet improves antitumor effect of vinblastine and the suppression of metastasis.
Dandamudi S; Patil V; Fowle W; Khaw BA; Campbell RB
Cancer Sci; 2009 Aug; 100(8):1537-43. PubMed ID: 19459849
[TBL] [Abstract][Full Text] [Related]
2. Synchrotron X-ray fluorescence studies of a bromine-labelled cyclic RGD peptide interacting with individual tumor cells.
Sheridan EJ; Austin CJ; Aitken JB; Vogt S; Jolliffe KA; Harris HH; Rendina LM
J Synchrotron Radiat; 2013 Mar; 20(Pt 2):226-33. PubMed ID: 23412478
[TBL] [Abstract][Full Text] [Related]
3. Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.
Tincu Iurciuc CE; Andrițoiu CV; Popa M; Ochiuz L
Polymers (Basel); 2023 Oct; 15(19):. PubMed ID: 37836018
[TBL] [Abstract][Full Text] [Related]
4. Challenges in Preparation of Albumin Nanoparticle-Based Radiopharmaceuticals.
Ballinger JR
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500689
[TBL] [Abstract][Full Text] [Related]
5. Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment.
Huang R; Li J; Kebebe D; Wu Y; Zhang B; Liu Z
Drug Deliv; 2018 Nov; 25(1):757-765. PubMed ID: 29528244
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line.
Yu X; Song Y; Di Y; He H; Fu D; Jin C
Sci Rep; 2016 Aug; 6():31539. PubMed ID: 27515795
[TBL] [Abstract][Full Text] [Related]
7. Application of albumin-based nanoparticles in the management of cancer.
Yu X; Jin C
J Mater Sci Mater Med; 2016 Jan; 27(1):4. PubMed ID: 26610927
[TBL] [Abstract][Full Text] [Related]
8. Co-opting biology to deliver drugs.
Yousefpour P; Chilkoti A
Biotechnol Bioeng; 2014 Sep; 111(9):1699-716. PubMed ID: 24916780
[TBL] [Abstract][Full Text] [Related]
9. Tumor Targeting via Integrin Ligands.
Marelli UK; Rechenmacher F; Sobahi TR; Mas-Moruno C; Kessler H
Front Oncol; 2013 Aug; 3():222. PubMed ID: 24010121
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements.
Xing H; Zheng X; Ren Q; Bu W; Ge W; Xiao Q; Zhang S; Wei C; Qu H; Wang Z; Hua Y; Zhou L; Peng W; Zhao K; Shi J
Sci Rep; 2013; 3():1751. PubMed ID: 23624542
[TBL] [Abstract][Full Text] [Related]
11. Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers.
Cho H; Balaji S; Sheikh AQ; Hurley JR; Tian YF; Collier JH; Crombleholme TM; Narmoneva DA
Acta Biomater; 2012 Jan; 8(1):154-64. PubMed ID: 21925628
[TBL] [Abstract][Full Text] [Related]
12. Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging.
Davies-Venn CA; Angermiller B; Wilganowski N; Ghosh P; Harvey BR; Wu G; Kwon S; Aldrich MB; Sevick-Muraca EM
Mol Imaging Biol; 2012 Jun; 14(3):301-14. PubMed ID: 21688052
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanospheres modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
Drug Deliv; 2010; 17(7):541-51. PubMed ID: 20560774
[TBL] [Abstract][Full Text] [Related]
14. Liposomes modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
J Drug Target; 2010 Jun; 18(5):373-80. PubMed ID: 20020817
[TBL] [Abstract][Full Text] [Related]
15. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature.
Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q
J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083
[TBL] [Abstract][Full Text] [Related]
16. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature.
Temming K; Schiffelers RM; Molema G; Kok RJ
Drug Resist Updat; 2005 Dec; 8(6):381-402. PubMed ID: 16309948
[TBL] [Abstract][Full Text] [Related]
17. cRGD functionalised nanocarriers for targeted delivery of bioactives.
Gajbhiye KR; Gajbhiye V; Siddiqui IA; Gajbhiye JM
J Drug Target; 2019 Feb; 27(2):111-124. PubMed ID: 29737883
[TBL] [Abstract][Full Text] [Related]
18. RGD modified albumin nanospheres for tumour vasculature targeting.
Dubey PK; Singodia D; Verma RK; Vyas SP
J Pharm Pharmacol; 2011 Jan; 63(1):33-40. PubMed ID: 21155813
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
